“This is a significant step forward in Crown’s vision to become a fully integrated global aesthetics and skincare company,” said Crown’s founder and CEO Jeff Bedard. He highlighted the potential to develop a comprehensive portfolio of high-growth products and the company’s commitment to supporting aesthetics providers across the United States.
Crown Buys Revance in $924M Deal : Future Prospects and Market Expansion
Revance President and CEO Mark J. Foley emphasized the strategic benefits of the merger, noting that the combined company’s scale and product range will provide a more compelling offering to customers. The merger is expected to close by the end of the year, contingent upon shareholder approval, regulatory clearances, and other standard closing conditions.
The merger represents a significant consolidation in the skincare and aesthetics industry, positioning Crown as a powerhouse in the global market.
